All In MedTech

Device Trial Radar · NCT07904065

Two Bovine Xenografts in Lateral Window Sinus Augmentation With or Without Bone Marrow Blood

Comparison of Two Anorganic Xenografts in the Lateral Window Maxillary Sinus Augmentation Technique With or Without Mandibular Bone Marrow Blood Admixture: Histomorphometric, Radiographic and Clinical Analysis

Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Jun 1, 2023

Primary completion

Mar 1, 2027

Study completion Jan 1, 2028

Sponsor

Lead sponsor
Universidad del DesarrolloAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 29, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Factorial
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 25 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn whether adding a small amount of blood taken from the jawbone marrow improves new bone formation when two different bone graft materials are used in maxillary sinus lift surgery. The study includes adults aged 25 to 65 who need more bone height in the upper back jaw before receiving dental implants. The main questions it aims to answer are: * Does InterOss (a bovine bone graft material) form a similar amount of new living bone as Bio-Oss (a widely used bovine bone graft material)? * Does mixing either graft material with bone marrow blood from the lower jaw increase the amount of new living bone and the bone height gained? Researchers will compare four groups: Bio-Oss alone, InterOss alone, Bio-Oss mixed with jawbone marrow blood, and InterOss mixed with jawbone marrow blood. Each treated sinus is randomly assigned to one group. Patients treated on both sides receive a different treatment on each side. Participants will: * Have a sinus lift surgery through a small side window in the upper jaw, where the sinus floor is filled with the assigned graft material. In two of the groups, a small amount of marrow blood (about 0.5 mL) will be drawn from the lower jaw and mixed with the graft. * Have a 3D dental X-ray (cone beam CT) before surgery and 8 months after surgery to measure the bone height gained. * Have dental implants placed 8 months after the sinus lift. During this surgery, a small bone sample will be taken from the grafted area and examined under a microscope. * Receive their implant-supported teeth about 6 months later and attend yearly check-up visits with a clinical exam and X-rays.

Conditions

  • Alveolar Bone Loss
  • Sinus Floor Augmentation
  • Edentulous Alveolar Ridge

Interventions

  • Deproteinized Bovine Bone Mineral (Bio-Oss)Device

    Deproteinized bovine bone mineral, large particle size (1-2 mm granules), manufactured by Geistlich Pharma AG (Wolhusen, Switzerland). Approximately 1-1.5 g is placed in the maxillary sinus after elevation of the Schneiderian membrane through a lateral window prepared with piezoelectric surgery. Used alone or mixed with mandibular marrow blood depending on the assigned arm. Reference (control) graft material.

  • Deproteinized Bovine Bone Mineral (InterOss)Device

    Deproteinized bovine bone mineral, large particle size (1-2 mm granules), manufactured by SigmaGraft Biomaterials (Fullerton, CA, USA). Approximately 1-1.5 g is placed in the maxillary sinus after elevation of the Schneiderian membrane through a lateral window prepared with piezoelectric surgery. Used alone or mixed with mandibular marrow blood depending on the assigned arm. Test graft material with physicochemical characteristics similar to Bio-Oss.

  • Mandibular Bone Marrow Blood AspirationProcedure

    Autologous bone marrow blood harvesting following a modified University of Michigan protocol. Through a small full-thickness flap in the retromolar/external oblique ridge area, the mandibular cortex is perforated 4-5 mm deep with a round carbide bur to reach the medullary space. Approximately 0.5 mL of marrow blood is aspirated with a heparinized 21G catheter and syringe, collected in a heparinized container, and mixed with the bovine bone graft immediately before placement in the sinus. No cell processing or culture is performed.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of New Vital Bone in the Augmented SinusTime frame: 8 months after sinus augmentation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Universidad del Desarrollo (UDD)

    Santiago, Santiago Metropolitan, Chile · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.